Literature DB >> 1431263

Association of genital infection with specific Chlamydia trachomatis serovars and race.

K A Workowski1, R J Suchland, M B Pettinger, W E Stamm.   

Abstract

Black race is an important risk marker for Chlamydia trachomatis genital infection. To define whether C. trachomatis serovars differ by ethnic distribution, a panel of monoclonal antibodies was used to serotype 934 urethral and 581 cervical isolates from patients attending a sexually transmitted diseases clinic over 2 years. The overall serovar distribution in cervical and urethral infections was comparable, with B class serovars predominating. Significantly higher inclusion counts were observed both in younger women and in nonblacks regardless of serovar. Serovar D was less frequent among blacks at the urethral site (P = .001), while serovar Ia was more frequent in blacks at both sites (urethral, P < .001; cervical, P = .02). These associations remained significant after adjusting for age and number of inclusion-forming units by multivariate analysis. Thus, specific serovars may be associated with particular racial groups; either behavioral or biologic factors could explain these findings.

Entities:  

Mesh:

Year:  1992        PMID: 1431263     DOI: 10.1093/infdis/166.6.1445

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Genotyping of Portuguese Chlamydia trachomatis urogenital isolates.

Authors:  M J Borrego; J P Gomes; J F Lefebvre; F Eb; J Orfila; M A Catry
Journal:  Genitourin Med       Date:  1997-12

2.  Comparison of two panels of monoclonal antibodies for determination of Chlamydia trachomatis serovars.

Authors:  J M Ossewaarde; M Rieffe; A de Vries; R P Derksen-Nawrocki; H J Hooft; G J van Doornum; A M van Loon
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

3.  Genotyping of Chlamydia trachomatis in urine specimens will facilitate large epidemiological studies.

Authors:  S A Morré; R Moes; I Van Valkengoed; J P Boeke; J T van Eijk; C J Meijer; A J Van den Brule
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Differences in clinical manifestations of genital chlamydial infections related to serovars.

Authors:  M J van de Laar; Y T van Duynhoven; J S Fennema; J M Ossewaarde; A J van den Brule; G J van Doornum; R A Coutinho; J A van den Hoek
Journal:  Genitourin Med       Date:  1996-08

5.  Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane.

Authors:  R J Suchland; D D Rockey; J P Bannantine; W E Stamm
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

6.  Maternal Antibodies to Chlamydia trachomatis and Risk of Gastroschisis.

Authors:  Samantha E Parker; Martha M Werler; Mika Gissler; Heljä-Marja Surcel
Journal:  Birth Defects Res       Date:  2017-02-24       Impact factor: 2.344

7.  Chlamydia trachomatis OmpA genotyping as a tool for studying the natural history of genital chlamydial infection.

Authors:  W M Geisler; C M Black; C I Bandea; S G Morrison
Journal:  Sex Transm Infect       Date:  2008-08-15       Impact factor: 3.519

8.  Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR.

Authors:  J Lan; I Melgers; C J Meijer; J M Walboomers; R Roosendaal; C Burger; O P Bleker; A J van den Brule
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.

Authors:  Anja Weinreich Olsen; Ida Rosenkrands; Martin J Holland; Peter Andersen; Frank Follmann
Journal:  NPJ Vaccines       Date:  2021-04-19       Impact factor: 9.399

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.